-
Publication Venue For
-
Adolescent alcohol use is linked to disruptions in age-appropriate cortical thinning: an unsupervised machine learning approach..
48:317-326.
2023
-
IN MEMORIAM Marc Caron 1946-2022..
47:1732.
2022
-
Noninvasive neuromodulation of the prefrontal cortex in mental health disorders..
47:361-372.
2022
-
Proof of concept study to develop a novel connectivity-based electric-field modelling approach for individualized targeting of transcranial magnetic stimulation treatment..
47:588-598.
2022
-
Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)..
46:2224.
2021
-
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders..
46:1802-1810.
2021
-
Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics..
46:1788-1801.
2021
-
Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings..
46:1272-1282.
2021
-
Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders..
46:844-850.
2021
-
Attention-deficit/hyperactivity disorder and the explore/exploit trade-off..
46:614-621.
2021
-
Neural correlates of conceptual-level fear generalization in posttraumatic stress disorder..
45:1380-1389.
2020
-
Altered network connectivity predicts response to cognitive-behavioral therapy in pediatric obsessive-compulsive disorder..
45:1232-1240.
2020
-
Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease..
45:1086-1096.
2020
-
Correction: Altered network connectivity predicts response to cognitive-behavioral therapy in pediatric obsessive-compulsive disorder..
45:1241.
2020
-
Increased subjective and reinforcing effects of initial nicotine exposure in young adults with attention deficit hyperactivity disorder (ADHD) compared to matched peers: results from an experimental model of first-time tobacco use..
45:851-856.
2020
-
Mechanistic link between right prefrontal cortical activity and anxious arousal revealed using transcranial magnetic stimulation in healthy subjects..
45:694-702.
2020
-
Combat exposure, posttraumatic stress disorder, and head injuries differentially relate to alterations in cortical thickness in military Veterans..
45:491-498.
2020
-
Genetics of the human circadian clock and sleep homeostat..
45:45-54.
2020
-
Is depression a disorder of electrical brain networks?.
45:230-231.
2020
-
Sleep therapeutics and neuropsychiatric illness..
45:166-175.
2020
-
Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial..
43:2197-2203.
2018
-
Parvalbumin Interneurons of the Mouse Nucleus Accumbens are Required For Amphetamine-Induced Locomotor Sensitization and Conditioned Place Preference..
43:953-963.
2018
-
ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge..
43:851-858.
2018
-
5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice..
42:2163-2177.
2017
-
Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats..
42:2128-2140.
2017
-
A Primer on Foraging and the Explore/Exploit Trade-Off for Psychiatry Research..
42:1931-1939.
2017
-
Minimum Electric Field Exposure for Seizure Induction with Electroconvulsive Therapy and Magnetic Seizure Therapy..
42:1192-1200.
2017
-
Attenuation of Frontostriatal Connectivity During Reward Processing Predicts Response to Psychotherapy in Major Depressive Disorder..
42:831-843.
2017
-
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder..
41:2961.
2016
-
Smoking Abstinence-Induced Changes in Resting State Functional Connectivity with Ventral Striatum Predict Lapse During a Quit Attempt..
41:2521-2529.
2016
-
SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept..
41:2324-2334.
2016
-
Dynamic Resting-State Functional Connectivity in Major Depression..
41:1822-1830.
2016
-
Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons..
41:1404-1415.
2016
-
Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury..
41:1191-1198.
2016
-
Amygdala, Hippocampus, and Ventral Medial Prefrontal Cortex Volumes Differ in Maltreated Youth with and without Chronic Posttraumatic Stress Disorder..
41:791-801.
2016
-
Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice..
41:704-715.
2016
-
Hippocampal and Insular Response to Smoking-Related Environments: Neuroimaging Evidence for Drug-Context Effects in Nicotine Dependence..
41:877-885.
2016
-
Altered Insula Activity during Visceral Interoception in Weight-Restored Patients with Anorexia Nervosa..
41:521-528.
2016
-
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia..
40:3053-3060.
2015
-
Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults..
40:2745-2752.
2015
-
Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia..
40:2705-2714.
2015
-
Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation Outcomes..
40:2648-2656.
2015
-
The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic Stress Disorder Enters the Age of Large-Scale Genomic Collaboration..
40:2287-2297.
2015
-
Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy..
40:2076-2084.
2015
-
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder..
40:2025-2037.
2015
-
Resting-state connectivity predictors of response to psychotherapy in major depressive disorder..
40:1659-1673.
2015
-
A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial..
40:1332-1342.
2015
-
Prediction of smoking cessation with treatment: the emerging contribution of brain imaging research..
40:1309-1310.
2015
-
Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior..
40:884-892.
2015
-
A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression..
39:2867-2873.
2014
-
Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling..
39:2750-2759.
2014
-
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia..
39:1568-1577.
2014
-
Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder..
39:1388-1398.
2014
-
Association of depressive symptoms with hippocampal volume in 1936 adults..
39:770-779.
2014
-
Meclizine enhancement of sensorimotor gating in healthy male subjects with high startle responses and low prepulse inhibition..
39:651-659.
2014
-
Altered resting-state functional connectivity of basolateral and centromedial amygdala complexes in posttraumatic stress disorder..
39:351-359.
2014
-
Nicotine deprivation influences P300 markers of cognitive control..
38:2525-2531.
2013
-
DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli..
38:1798-1807.
2013
-
Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density..
38:1548-1556.
2013
-
Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia..
38:1245-1252.
2013
-
A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons..
38:854-862.
2013
-
Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin..
37:321-337.
2012
-
Somatic treatments for mood disorders..
37:102-116.
2012
-
The MATRICS consensus cognitive battery in patients with bipolar I disorder..
36:1587-1592.
2011
-
Child μ-opioid receptor gene variant influences parent-child relations..
36:1165-1170.
2011
-
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia..
36:616-626.
2011
-
Failures in learning-dependent predictive perception as the key cognitive vulnerability to psychosis in schizophrenia..
36:367-368.
2011
-
Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control..
35:2600-2606.
2010
-
Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies..
35:1053-1062.
2010
-
Imaging and genetics advances in understanding geriatric depression..
35:349-350.
2010
-
Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction..
34:2002-2010.
2009
-
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia..
34:1885-1903.
2009
-
Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients..
34:1819-1828.
2009
-
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial..
34:522-534.
2009
-
Metabolomics: a global biochemical approach to the study of central nervous system diseases..
34:173-186.
2009
-
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study..
33:2810-2819.
2008
-
Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats..
33:2922-2933.
2008
-
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity..
33:2303-2312.
2008
-
Combined Agonist-Antagonist Treatment for Nicotine and Other Drug Dependencies..
11:281.
1994
-
Comparison of brain nicotine uptake from electronic cigarettes and combustible cigarettes.
2022